Management of TRK Fusion Cancer: Evaluating Targeted Therapies - Participating FacultyJanuary 11th 2022
Diagnosis and Management of TRK Fusion CancerByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MDJanuary 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion CancerByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPhJanuary 11th 2022
